Iran unveils breakthrough regenerative therapies for severe burns and diabetic wounds
An Iranian research center has announced major progress in regenerative medicine, with multiple domestically developed products receiving market approval, including therapies aimed at severe burns and long-standing diabetic wounds.
The head of the Royan AtiTech Pharmed (ATP), which focuses on cell and gene therapy technology, announced the developments, saying six “high-tech” products operating at the cutting edge of cell therapy, tissue engineering, and gene therapy had secured licenses to enter the market, Tasnim News Agency reported on Monday.
Ensieh Hajizadeh noted that because of the complexity of the underlying technologies, many of the products were not widely available in numerous countries, while their localization and regulatory approval had advanced rapidly inside the Islamic Republic.
According to her, the newly-licensed products reflected years of research in advanced cellular technologies. Their development and approval marked a significant step in translating laboratory research into clinical and commercial applications, Hajizadeh added.
Extensive burns
Among the licensed products was one patented as “Rouyin-Sheet” and described as a skin layer containing living cells. The product is presented as one of the most effective treatments for extensive burns and is designed to prevent scarring without the need for immunosuppression.
The center said the product had been produced domestically at a cost less than one-tenth of comparable foreign ones, a factor that gives it what the official described as strong export potential and the capacity to generate foreign currency.
Chronic diabetic wounds
Another product highlighted by the center was “Rouyin-Graft,” a complete, two-layer skin tissue. The technology is designed to replace the painful process of harvesting skin from a patient’s own body for grafting.
According to the interview, “Rouyin-Graft” has been used successfully to treat chronic diabetic wounds, including cases up to 20 years old that had not responded to other treatment methods.
Market entry and outlook
The center said the licensing of these products paved the way for their broader clinical use and market entry.
Experts noted that the developments placed advanced cellular and tissue-engineering technologies among the center’s key areas of applied research, with an emphasis on domestic production and accessibility.
Iran leads Islamic world in electric vehicle motor technology
Iran’s biotech leap into global elite club of seahorse breeders
Iran unveils, inaugurates three homegrown strategic space projects
VIDEO | Protests erupt across Australia over Israeli president's visit
Iran maps strategic future in 1st Congress on Foreign Policy and History of Foreign Relations
VIDEO | At least nine killed in multi-building collapse in Lebanon
Rights group: 'Administrative detention' of Palestinians up 270% since Gaza genocide started
Leader urges nation to ‘frustrate enemy’ on Islamic Revolution anniversary
Cuba suspends airline refueling amid US economic pressure
Iran unveils breakthrough regenerative therapies for severe burns and diabetic wounds
Iran stands as Muslim world’s final frontier of resistance against imperialism and Zionism
PressTV NEWSLETTER
now
This makes it easy to access the Press TV website
